Abatacept, a fusion protein combining cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) with the Fc portion of IgG1, modulates CD80/CD86:CD28 signaling and is approved for rheumatoid arthritis [142]. Here, CTLA4 is linked to rheumatoid arthritis.